Syros Pharmaceuticals, Inc. Syros Pharmaceuticals, Inc.
  • Home
  • Our Coordinated Expression
    • Overview
    • Our Culture, Mission & Values
    • Our Commitment to Diversity, Equity & Inclusion
    • Message from BIO
  • Our People
    • Overview
    • Leadership
    • Board of Directors
  • Programs
    • Overview
    • Tamibarotene
    • SY-2101
    • SY-5609
    • Expanded Access Policy
  • Clinical Trials
  • Platform
    • Overview
    • What is Gene Control?
    • Publications and Abstracts
  • Patients
  • Investors & Media
  • Partners
  • Careers
  • Blog
  • Contact
Investors & Media

Investors & Media

  • Overview
  • News
    • Email Alerts
    • Press Releases
  • Events & Presentations
    • IR Calendar
    • Presentations
  • Company Info
    • Fact Sheet
    • Profile
    • Leadership
    • Contacts
    • Analyst Coverage
    • FAQ
  • Financial Info
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Annual Reports
    • IRS Tax Form 8937
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • All SEC Filings
    • Annual Filings
    • Quarterly Reports
    • Proxy
    • Section 16 Filings
  • Governance
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Investor & Media Tools
    • Email Alerts
    • Fact Sheet
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

  • News

  • Email Alerts
  • Press Releases
Sep 8, 2015

Syros Pharmaceuticals to Participate in September Investor Conferences

Aug 5, 2015

Syros Pharmaceuticals to Participate in August Investor Conferences

Jul 6, 2015

Syros Pharmaceuticals Announces Appointment of CEO Nancy Simonian to BIO Board

Jun 18, 2015

Syros Pharmaceuticals to Present at 2015 JMP Securities Life Sciences Conference

Apr 15, 2015

Syros Pharmaceuticals to Present New Data from its Gene Control Platform in AML and Breast Cancer at AACR Annual Meeting 2015

Mar 20, 2015

Syros Pharmaceuticals Announces New Research Published on Role of Cell Signaling Pathways in Gene Control

Feb 24, 2015

Syros Pharmaceuticals to Present at Leading Investor Conferences

Feb 10, 2015

Syros Pharmaceuticals Presents New Data on Use of its Gene Control Platform for Predicting Drug Response

Feb 9, 2015

Syros Pharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference

Jan 7, 2015

Syros Pharmaceuticals to Present at the 33rd Annual J.P. Morgan 2015 Healthcare Conference

RSS
    • 1...
    • 19
    • 20
    • 21
    • 22
    • 23
    • 24
    • 25
    • 26
    • 27
    • 28
    © 2023 Syros Pharmaceuticals, Inc. All Rights Reserved.
    Privacy Policy Terms of Use Sitemap
    twitter logo linkedin logo